Search - tctmd.com

Displaying 561 - 580 of 1307

Sort: Relevancy | Date

News Industry News

Abbott Announces European Approval Of Two Life-Saving Heart Devices For Babies And Children

September 17, 2019

News Industry News

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

September 12, 2019

News Conference News ESC 2019

Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease

L.A. McKeown

September 05, 2019

News Industry News

Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves

September 05, 2019

News Daily News

Aborted TAVR Procedures Are Waning in the US

Shelley Wood

August 28, 2019

News Daily News

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Caitlin E. Cox

August 21, 2019

News Daily News

Late Follow-up of Surgical MV Repair: Insights for Timing, Innovation

Shelley Wood

August 20, 2019

News Featured Fellow

Shane Prejean, MD

Yael L. Maxwell

August 20, 2019

News Daily News

No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study

Michael O'Riordan

August 19, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Industry News

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

August 16, 2019

News Daily News

Earlier Care, More Data Needed to Increase Treatment Success in Tricuspid Regurgitation

Yael L. Maxwell

August 07, 2019

News Daily News

TAVR Bleeds Stand Apart From PCI-Related Events

Caitlin E. Cox

August 06, 2019

News Opinion Fellow Talk

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

Yashasvi Chugh, MD

August 05, 2019

News Features

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

Yael L. Maxwell

August 02, 2019

News Daily News

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Todd Neale

July 29, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Industry News

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

July 16, 2019

News Industry News

Abbott Receives U.S. Approval Of Next-Generation Mitraclip™, Bringing New Enhancements To Abbott's Leading Mitraclip Platform

July 15, 2019

News Daily News

Elevated BP Linked to Risk of Valvular Heart Disease, Including Aortic Stenosis

Michael O'Riordan

July 12, 2019

Advertisement

Abbott Announces European Approval Of Two Life-Saving Heart Devices For Babies And Children

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease

Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves

Aborted TAVR Procedures Are Waning in the US

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Late Follow-up of Surgical MV Repair: Insights for Timing, Innovation

Shane Prejean, MD

No Volume-Outcome Link With Watchman for LAA Closure? Single-Center Study

FDA Expands TAVR Indication to Low-Risk Patients

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

Earlier Care, More Data Needed to Increase Treatment Success in Tricuspid Regurgitation

TAVR Bleeds Stand Apart From PCI-Related Events

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

Abbott Receives U.S. Approval Of Next-Generation Mitraclip™, Bringing New Enhancements To Abbott's Leading Mitraclip Platform

Elevated BP Linked to Risk of Valvular Heart Disease, Including Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content